Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S. Noto is active.

Publication


Featured researches published by S. Noto.


Value in Health | 2016

Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan

Takeru Shiroiwa; Shunya Ikeda; S. Noto; Ataru Igarashi; Takashi Fukuda; Shinya Saito; Kojiro Shimozuma

BACKGROUND The valuation study of the five-level version of the EuroQol five-dimensional questionnaire (EQ-5D-5L) involved composite time trade-off (cTTO) and a discrete choice experiment (DCE). The DCE scores must be anchored to the quality-of-life scale from 0 (death) to 1 (full health). Nevertheless, the characteristics of the statistical methods used for converting the EQ-5D-5L DCE results by using TTO information are not yet clearly known. OBJECTIVES To present the Japanese DCE value set of the EQ-5D-5L and compare three methods for converting latent DCE values. METHODS The survey sampled the general population at five locations in Japan. 1098 respondents were stratified by age and sex. To obtain and compare the value sets of the EQ-5D-5L, the cTTO and DCE data were analyzed by a linear mixed model and conditional logit, respectively. The DCE scores were converted to the quality-of-life scale by anchoring to the worst state using cTTO, mapping DCE onto cTTO, and a hybrid model. RESULTS The data from 1026 respondents were analyzed. All the coefficients in the cTTO and DCE value sets were consistent throughout all the analyses. Compared with the cTTO algorithm, the mapping and hybrid methods yielded very similar scoring coefficients. The hybrid model results, however, produced a lower root mean square error and fewer health states with errors exceeding 0.05 than did the other models. The DCE anchored to the worst state overestimated the cTTO scores of almost all the health states. CONCLUSIONS Japanese value sets based on DCE were demonstrated. On comparing the observed cTTO scores, we found that the hybrid model was slightly superior to the simpler methods, including the TTO model.


Journal of Bone and Mineral Research | 2013

Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan.

Kensuke Moriwaki; Hirotaka Komaba; S. Noto; Shinichiro Yanagisawa; Toru Takiguchi; H. Inoue; Takeshi Toujo; Masafumi Fukagawa; Hideaki E. Takahashi

Many postmenopausal women have osteopenia, a condition characterized by loss of bone mineral density (BMD) that is not as severe as in osteoporosis. The objective of this study was to estimate the cost‐effectiveness of alendronate to prevent fractures in osteopenic postmenopausal women without a history of fracture in Japan. An individual simulation model was developed to predict lifetime costs and quality‐adjusted life years (QALYs) of 5 years of preventive alendronate therapy versus no preventive therapy. The risk of hip and vertebral fracture associated with age and BMD was derived from epidemiologic studies in Japan. We ran the model with different combinations of age (65, 70, and 75 years), BMD (70%, 75%, and 80% of young adult mean [YAM]), and additional clinical risk factors. For 70‐year‐old women with a BMD of 70% of the YAM having one of the following risk factors: a family history of hip fracture, high alcohol intake, or current smoking, the incremental cost‐effectiveness ratio (ICER) of alendronate was


Osteoporosis International | 2017

Economic evaluation of osteoporosis liaison service for secondary fracture prevention in postmenopausal osteoporosis patients with previous hip fracture in Japan

K. Moriwaki; S. Noto

92,937,


Applied Health Economics and Health Policy | 2016

Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making

Takeru Shiroiwa; Shinya Saito; Kojiro Shimozuma; Satoshi Kodama; S. Noto; Takashi Fukuda

126,251, and


Quality of Life Research | 2016

Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D

Takeru Shiroiwa; Takashi Fukuda; Shunya Ikeda; Ataru Igarashi; S. Noto; Shinya Saito; Kojiro Shimozuma

129,067 per QALY, respectively. These results were sensitive to age, BMD, and number of clinical risk factors. Probabilistic sensitivity analysis for the base case showed that in the presence of one, two, and three risk factors, alendronate was cost‐effective in 0.2% to 2.6%, 13.1% to 56.1%, and 99.1% of the simulations, respectively, if society is willing to pay


Journal of the National Institute of Public Health | 2015

Developing a Japanese version of the EQ-5D-5L value set

Shunya Ikeda; Takeru Shiroiwa; Ataru Igarashi; S. Noto; Takashi Fukuda; Shinya Saito; Kojiro Shimozuma

50,000 per QALY. Additional analysis indicated that alendronate can be a good value in osteopenic women if the 10‐year probability for a osteoporotic hip or vertebral fracture is more than 26.2%. Our results indicate that whether to treat osteopenia with alendronate should be determined on the basis of age, BMD, and number of clinical risk factors in terms of cost‐effectiveness.


Value in Health | 2011

PCV73 CONSTRUCT VALIDITY OF HEALTH UTILITIES INDEX (HUI) JAPANESE VERSION: CROSS-SECTIONAL STUDY FOR STROKE IN JAPAN

S. Noto; Takamoto Uemura; R. Izumi; Kensuke Moriwaki

SummaryA model-based cost-effectiveness analysis was performed to evaluate the cost-effectiveness of secondary fracture prevention by osteoporosis liaison service (OLS) relative to no therapy in patients with osteoporosis and a history of hip fracture. Secondary fracture prevention by OLS is cost-effective in Japanese women with osteoporosis who have suffered a hip fracture.IntroductionThe purpose of this study was to estimate, from the perspective of Japan’s healthcare system, the cost-effectiveness of secondary fracture prevention by OLS relative to no therapy in patients with osteoporosis and a history of hip fracture.MethodsA patient-level state transition model was developed to predict lifetime costs and quality-adjusted life years (QALYs) in patients with or without secondary fracture prevention by OLS. The incremental cost-effectiveness ratio (ICER) of secondary fracture prevention compared with no therapy was estimated. Sensitivity analyses were performed to examine the influence of parameter uncertainty on the base case results.ResultsCompared with no therapy, secondary fracture prevention in patients aged 65 with T-score of −2.5 resulted in an additional lifetime cost of


Osteoporosis International | 2017

A model-based cost-effectiveness analysis of osteoporosis screening and treatment strategy for postmenopausal Japanese women

M. Yoshimura; K. Moriwaki; S. Noto; Toru Takiguchi

3396 per person and conferred an additional 0.118 QALY, resulting in an ICER of


Value in Health | 2015

Validation of Fracture Risk Model In Japanese Women Compared With Frax.

K. Moriwaki; S. Noto

28,880 per QALY gained. Deterministic sensitivity analyses showed that treatment duration and offset time strongly affect the cost-effectiveness of OLS. According to the results of scenario analyses, secondary fracture prevention by OLS was cost-saving compared with no therapy in patients with a family history of hip fracture and high alcohol intake.ConclusionsSecondary fracture prevention by OLS is cost-effective in Japanese women with osteoporosis who have suffered a hip fracture. In addition, secondary fracture prevention is less expensive than no therapy in high-risk patients with multiple risk factors.


Japanese Journal of Pharmacoepidemiology\/yakuzai Ekigaku | 2012

6. The Ethics of the Allocation of Health Care Resources and QALY

Shinya Saito; Satoshi Kodama; Takeru Shiroiwa; Kojiro Shimozuma; S. Noto; Reiko Goto

Background and ObjectivesAlthough quality-adjusted life-years (QALYs) may not completely reflect the value of a healthcare technology, it remains unclear how to adjust the cost per QALY threshold. First, the present study compares two survey methods of measuring people’s preferences for a specific healthcare technology when each choice has the same efficiency. The second objective was to consider how this information regarding preferences could be used in decision making.MethodsWe conducted single-attribute (budget allocation) and multi-attribute (discrete-choice) experiments to survey public medical care preferences. Approximately 1000 respondents were sampled for each experiment. Six questions were prepared to address the attributes included in the study: (a) age; (b) objective of care; (c) disease severity; (d) prior medical care; (e) cause of disease; and (f) disease frequency. For the discrete-choice experiment (a) age, (b) objective of care, (c) disease severity, and (d) prior medical care were orthogonally combined. All assumed medical care had the same costs and incremental cost-effectiveness ratio (ICER; cost per life-year or QALY). We also calculated the preference-adjusted threshold (PAT) to reflect people’s preferences in a threshold range.ResultsThe results of both experiments revealed similar preferences: intervention for younger patients was strongly preferred, followed by interventions for treatment and severe disease states being preferred, despite the same cost per life-year or QALY. The single-attribute experiment revealed that many people prefer an option in which resources are equally allocated between two interventions. Marginal PATs were calculated for age, objective of care, disease severity, and prior medical care.ConclusionThe single- and multi-attribute experiments revealed similar preferences. PAT can reflect people’s preferences within the decision-maker’s threshold range in a numerical manner.

Collaboration


Dive into the S. Noto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kensuke Moriwaki

Niigata University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

Shunya Ikeda

International University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

R. Izumi

Niigata University of Health and Welfare

View shared research outputs
Top Co-Authors

Avatar

K Moriwaki

Kobe Pharmaceutical University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge